|
|
||||||||
Eur J Cardiothorac Surg 2004;25:1072-1078
© 2004 Elsevier Science NL
a Department of Thoracic Surgery, Dicle University School of Medicine, Diyarbakir, Turkey
b Department of Pharmacology, Dicle University School of Medicine, Diyarbakir, Turkey
c Department of Thoracic Surgery, Adnan Menderes University School of Medicine, Diyarbakir, Turkey
d Department of Biostatistics, Dicle University School Of Medicine, Diyarbakir, Turkey
Received 29 June 2003; received in revised form 9 December 2003; accepted 18 December 2003.
* Corresponding author. Tel.: +90-412-2488-001; fax: +90-412-2488-520
e-mail: cozcelik{at}dicle.edu.tr
Objectives: Despite continued improvement in medical therapy, pediatric empyema remains a challenging problem for the surgeon. Multiple treatment options are available; however, the optimal therapeutic management has not been elucidated. The aim of this study is to assess different treatment options in the management of postpneumonic pediatric empyemas. Methods: A retrospective review was performed of pediatric patients admitted to Dicle University School of Medicine Thoracic and Cardiovascular Surgery Department between 1990 and 2002, with the diagnosis of empyema. Data tabulated included patient demographics, presentation, treatment and outcome. Results: There were 515 children (289 boys and 226 girls) with a mean age of 4.7 ranging from 18 days to 15 years. Empyema was secondary to pneumonia in all children. The most common radiologic finding was pleural effusion in 285 patients (55.32%). Staphylococcus aureus was the most frequently encountered organism and found in 105 patients (20.38%). Pleural fluid cultures were negative in 195 patients (37.86%). In addition to antibiotic therapy, initial treatment included serial thoracenthesis (n=29), chest tube drainage alone (n=214), chest tube drainage with intrapleural fibrinolytic therapy (n=72), chest tube drainage with primary operation (n=191), and primary operation without chest tube drainage (n=9). Overall response rate with fibrinolytic treatment (complete and partial response) was obtained in 58 patients. In addition to decortication pulmonary resections were performed in 12 patients. Overall mortality rate was 1.55%. There was no operative mortality. Postoperative morbidity included wound infection in 21, delayed expansion in 8, and atelectasis in 35 patients. Conclusions: Multiple therapeutic options are available for the management of pediatric empyema. Depending on stages, every option has a role in the treatment of postpneumonic pediatric empyema. In the absence of bronchopleural fistula, intrapleural fibrinolytic treatment should be tried in all patients with multiloculations in stage II empyema. In the absence of pneumonia, decortication for empyema is a safe approach with low mortality and morbidity rates.
Key Words: Empyema Fibrinolytic treatment Decortication Postpneumonic
This article has been cited by other articles:
![]() |
J. R. Avansino, B. Goldman, R. S. Sawin, and D. R. Flum Primary Operative Versus Nonoperative Therapy for Pediatric Empyema: A Meta-analysis Pediatrics, June 1, 2005; 115(6): 1652 - 1659. [Abstract] [Full Text] [PDF] |
||||
![]() |
I M Balfour-Lynn, E Abrahamson, G Cohen, J Hartley, S King, D Parikh, D Spencer, A H Thomson, D Urquhart, and on behalf of the Paediatric Pleural Diseases Subco BTS guidelines for the management of pleural infection in children Thorax, February 1, 2005; 60(suppl_1): i1 - i21. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |